Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 664

Results For "C"

9177 News Found

physIQ and CellCarta collaborate to personalise vaccine development
Biotech | March 21, 2022

physIQ and CellCarta collaborate to personalise vaccine development

Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness


Zydus receives PAS approval for Mycophenolate Mofetil
Drug Approval | March 21, 2022

Zydus receives PAS approval for Mycophenolate Mofetil

The drug is indicated for use in combination with other drugs


Mylab to open new facility in Vishakhapatnam
News | March 21, 2022

Mylab to open new facility in Vishakhapatnam

Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis


Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
News | March 21, 2022

Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India

Sputnik Light is the first component of Sputnik V


Augnito.ai offers new features to woo doctors to its platform
Startup | March 21, 2022

Augnito.ai offers new features to woo doctors to its platform

Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform


Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets
Drug Approval | March 21, 2022

Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets

The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older


Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK
Biotech | March 21, 2022

Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK

The facility will produce 150 million vaccine doses per year


ABclonal Technology joins YCharOS advisory committee to tackle reproducibility crisis in biomedical research
Biotech | March 21, 2022

ABclonal Technology joins YCharOS advisory committee to tackle reproducibility crisis in biomedical research

Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research


RNAGene and PharmAbcine to develop novel mRNA therapeutics
Biotech | March 21, 2022

RNAGene and PharmAbcine to develop novel mRNA therapeutics

mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody


Lonza signs manufacturing agreement with Oasmia Pharmaceutical
News | March 21, 2022

Lonza signs manufacturing agreement with Oasmia Pharmaceutical

Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply